Ajinomoto Bio-Pharma

ADC deals: Ajinomoto and Exelixis team up, French biotech secures funding for payload program

10-Jan-2023 By Jane Byrne

There has been a flurry of antibody-drug conjugate (ADC) agreements in recent weeks, and today sees the inking of another deal involving Tokyo headquartered Ajinomoto Co Inc and US biotech, Exelixis.

From the show floor: Exhibitors at CPhI Worldwide 2021

03-Nov-2021 By Rachel Arthur

CPhI Worldwide welcomes attendees back to the show floor in person this month. We put the spotlight on some of the exhibitors who will be there.

Webinar delves into drug delivery innovations

09-Jul-2020 By Jenni Spinner

Innovations in Drug Delivery Part II, a free online event on July 15, will feature novel technologies and innovative solutions to current challenges.

Ajinomoto to produce potential COVID-19 treatment for CytoDyn

05-May-2020 By Ben Hargreaves

Ajinomoto agrees partnership to manufacture leronlimab, which is currently undergoing clinical trials for the treatment of COVID-19.

GeneDesign opens large-scale production facility in Osaka

23-Apr-2019 By Vassia Barba

The Ajinomoto subsidiary opens a development and production base for oligonucleotide drug substances in Japan.

Ajinomoto continues $100m investment to build out worldwide services

26-Mar-2019 By Ben Hargreaves

Aji Bio-Pharma will add a flexible fill line, packaging and labelling equipment to its worldwide manufacturing network, in an investment worth upwards of $100m.